News

Clinical Study Seeks Participants with Lung Disease

Published Date:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes harder to take deep breaths. The lungs become unable to take in enough oxygen.

Dr. Rajagopal Sreedhar is recruiting participants for a clinical trial to see if pulmonary rehabilitation treatments improve the quality of life for patients with IPF. The study will compare standard of care treatment to exercise and education. The goal is test how well the combination of exercise and medication benefits the patient. All study-related visits and tests will be provided at no cost to the participant. Participants may also receive a stipend to cover travel and other related expenses.

To qualify, participants must:

  • Be 40 years of age or older
  • Have been diagnosed with IPF
  • Be currently taking the medication Ofev® (150 mg twice a day) and have taken it at a stable dose for up to 30 months

To learn more about this study, contact Abigail House, RN, at 217-545-7526.

More from SIU News

SIU Medicine Express Care

Memorial Care to transition North Dirksen Urgent Care Clinic to SIU Medicine

Memorial Health and SIU Medicine have announced plans to transition the urgent care clinic at Memorial Care on North Dirksen Parkway to a federally qualified health center (FQHC) administered by SIU Medicine this summer.
Azhar U.S. Citizenship

Dr. Waqas Azhar welcomed as U.S. citizen

SIU oncologist Dr. Waqas Azar and his wife, Dr. Noor Khalid, joined 76 other guests from around the world this spring at the Abraham Lincoln Presidential Museum to take the U.S. Oath of Citizenship.
butterfly on lazy susan

Butterfly release to honor loved ones, celebrate survivors June 8

Simmons Cancer Institute (SCI) at SIU Medicine will host its 16th Annual Butterfly Release at 10 a.m. on Saturday, June 8, in the Thomas Garden of Hope, Simmons Cancer Institute, 315 W. Carpenter St